BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to boost immune system against pancreatic cancer before surgery
Disease control OngoingThis study is testing a four-drug combination given to patients before surgery for pancreatic cancer that can be removed. The treatment includes two standard chemotherapy drugs and two newer immunotherapy drugs designed to help the body's immune system fight the cancer. The main …
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Nanoparticle 'Booster' tested to make radiation more powerful against tough pancreatic tumors
Disease control TerminatedThis early-stage study is testing a new experimental treatment called NBTXR3 for people with locally advanced pancreatic cancer that is difficult to remove with surgery. The treatment involves injecting tiny nanoparticles directly into the tumor, which are then activated by a sta…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope in fight against pancreatic cancer
Disease control OngoingThis study is testing new treatments for people with pancreatic cancer that has not spread widely. It compares experimental therapies to current standard treatments. The goal is to see if the new approaches can better control the cancer, shrink tumors before surgery, or help pati…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC